September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
OUTCOME OF IMPLANTABLE COLLAMER LENS IN KERATOCONUS
Author Affiliations & Notes
  • salem G almalki
    OPHATHALMOLOGY, KING KHALID EYE SPECIALIST HOSPITAL, RIAYDH, Saudi Arabia
  • Footnotes
    Commercial Relationships   salem almalki, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2904. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      salem G almalki; OUTCOME OF IMPLANTABLE COLLAMER LENS IN KERATOCONUS. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2904.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To assess the safety and efficacy of collamer lens (ICL) in the posterior chamber for correction of myopia and astigmatism in patients with keratoconus

Methods : A retrospective chart review was conducted of 27 patients diagnosed as keratoconus underwent ICL (Model V4) insertion, performed by different surgeons .All ICL surgeries and preoperative evaluations were performed at tertiary hospital

Results : There was a statistically significant increase in mean UCVA from 20/200(range: 20/80 - count fingure) preoperatively to 20/30 (range: 20/20 – 20/100) at the last postoperative visit (P < 0.0001). There was statistically significant decrease in mean MRSE (Manifest refractive spherical equivalent) from - 8.36 ± 3.67 D (range, -2 to - 16 D) preoperatively to -0.56 ± 1.00 D (range, -2 to 1 D) postoperatively (P < 0.0001). Mean improvement in postoperative BCVA was 1 line compared to preoperatively. At the last postoperative visit, 28.6% of eyes had a BCVA of 20/20 or better compared with only 17.85% preoperatively. No intraoperative or postoperative complications occurred

Conclusions : Our study yielded favorable results compared to other studies in the literature. However, a larger number of patients and a longer follow-up period are needed to truly assess the efficacy of ICL in the management of keratoconus with high myopia and moderate-to-high myopic astigmatism

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×